Back
HFA Premium Access

The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors

Session: ePosters in cardiovascular disease in special populations 1
Topic: Cardio-Oncology
Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)
Event: Heart Failure 2023

Congress Presentation

About the speaker

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
0 follower

6 more presentations in this session

A new maternal heart clinic - early experiences and challenges in a quaternary hospital in Western Australia.

Speaker: Doctor R. Chetty (Perth, AU)

Access
Abstract
Slides
Thumbnail

Safety and utility of cardiopulmonary exercise testing in non-Hodgkin lymphoma patients undergoing chemotherapy

Speaker: Doctor D. Bursacovschi (Chisinau, MD)

Access
Abstract
Slides
Thumbnail

Plasminogen activator inhibitor -1 and circulating ceruloplasmin levels in men with heart failure with preserved ejection fraction with concomitant prostate cancer

Speaker: Doctor O. Sirenko (Dnipro, UA)

Access
Abstract
Slides
Thumbnail

Relationship between clinical and echocardiographic outcomes and cardioprotective drugs in a population of female breast cancer patients exposed to anthracyclines

Speaker: Doctor C. Oliveira (Porto, PT)

Access
Abstract
Slides
Thumbnail

Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients

Speaker: Doctor A. Cuomo (Le Plessis Robinson, FR)

Access
Abstract
Slides
Thumbnail

Access the full session

ePosters in cardiovascular disease in special populations 1

Speakers: Doctor M. Laufer-Perl, Doctor R. Chetty, Doctor D. Bursacovschi, Doctor O. Sirenko, Doctor C. Oliveira...
Access
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb